Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Laboratorios Farmaceuticos Rovi ( (ES:ROVI) ) has shared an announcement.
Laboratorios Farmacéuticos ROVI has announced the call for its Ordinary General Shareholders’ Meeting scheduled for June 18, 2025. The meeting will address several key issues, including the proposal to distribute a dividend of 0.9351 euros per share for the 2024 financial year. This announcement reflects ROVI’s commitment to maintaining transparency and engaging with its shareholders, potentially impacting its financial outlook and investor relations.
More about Laboratorios Farmaceuticos Rovi
Laboratorios Farmacéuticos ROVI, S.A. operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company is known for its specialization in the production of injectables and other pharmaceutical formulations, catering to both domestic and international markets.
Average Trading Volume: 131,908
Technical Sentiment Signal: Sell
Current Market Cap: €2.63B
For a thorough assessment of ROVI stock, go to TipRanks’ Stock Analysis page.